已发表论文

襄阳地区凝血因子 V c.3865T>G 突变与遗传及地域易感性对脑静脉和静脉窦血栓形成的影响研究

 

Authors Zhang J, Liu Q, Sun C, Yang J

Received 21 January 2025

Accepted for publication 5 August 2025

Published 13 August 2025 Volume 2025:21 Pages 645—653

DOI https://doi.org/10.2147/VHRM.S518609

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Daniel Duprez

Jun Zhang,1,* Qian Liu,2,* Chenglin Sun,1 Jun Yang1 

1Department of Neurology, Xiangyang No.1 People’s Hospital, Hubei University of Medicine, Xiangyang, 441000, People’s Republic of China; 2Department of Oncology, Xiangyang No.1 People’s Hospital, Hubei University of Medicine, Xiangyang, 441000, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Chenglin Sun, Department of Neurology, Xiangyang No. 1 People’s Hospital, Hubei University of Medicine, Jiefang Road No. 15, Xiangyang, Hubei, 441000, People’s Republic of China, Email sunchenglin1813@126.com Jun Yang, Department of Neurology, Xiangyang No. 1 People’s Hospital, Hubei University of Medicine, Jiefang Road No. 15, Xiangyang, Hubei, 441000, People’s Republic of China, Email 296051103@qq.com

Objective: This study investigates the potential genetic and regional associations of a newly identified c.3865T>G mutation in the F5 gene (coagulation factor V) with cerebral venous and sinus thrombosis (CVST).
Methods: Two groups of CVST cases associated with hereditary thrombophilia were analyzed. Genetic sequencing was performed to identify the patients’ genetic profiles. A family pedigree analysis and a review of relevant literature were conducted to assess the pathogenic significance of the mutation.
Results: Genetic analysis revealed the presence of a c.3865T>G mutation in the F5 gene in both cases. This mutation is distinct from the well-established Leiden mutation and has not been previously reported. Although the two patients’ families had no direct blood relationship, both patients resided in the same geographic region, suggesting the possibility of shared environmental or genetic factors. Advances in diagnostic technologies have also facilitated the identification of hereditary thrombophilia as an increasingly recognized cause of CVST.
Conclusion: The c.3865T>G mutation in the F5 gene may represent a novel genetic contributor to CVST. Its regional clustering points to a potential genetic and geographic association. These findings provide new insights into the etiology and diagnosis of CVST and underscore the importance of investigating regional genetic predispositions further.

Keywords: CVST, F5 gene c.3865T>G mutation, hereditary thrombophilia, genetic predisposition, regional association